Jing Li

ORCID: 0000-0002-2037-5817

Also affiliated with Sun Yat-sen University, Hengshui University, German Cancer Research Center, Chinese Academy of Medical Sciences & Peking Union Medical College, Heidelberg University, Anhui University of Traditional Chinese Medicine, University Hospital Heidelberg, Chinese PLA General Hospital, Beijing Geriatric Hospital, Sinocelltech Group (China), National Center for Tumor Diseases, Hopp Children's Cancer Center Heidelberg, Sun Yat-sen University Cancer Center, Central Hospital of Zibo, Deutsches Konsortium für Translationale Krebsforschung, Beihang University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Reticulocalbin 2 as a Potential Biomarker and Therapeutic Target for Atherosclerosis”.

Reticulocalbin 2 as a Potential Biomarker and Therapeutic Target for Atherosclerosis

Cells(2022)10.3390/cells11071107

N/A

0DataRank · unranked

12 citations

Angela M. Taylor, Ani Manichaikul, John F. Angle, Weibin Shi, Jing Li

Response of treatment-naive brain metastases to stereotactic radiosurgery

Nature Communications(2024)10.1038/s41467-024-47998-8

N/A

0DataRank · unranked

27 citations

Christina Abi Faraj, Thomas H. Beckham, Jeffrey S. Weinberg, Clark R. Andersen, Ali S. Haider +24 more